415 patents currently held
37 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
23 more records may belong here and await a decision; they are not counted.
The next term ends in Dec 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
94
Ending by 2030
Dec 2026
Next term end
313
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2027 · High confidence
Also notable
Ends Oct 2038 · High confidence
Also notable
Ends Apr 2027 · High confidence
Blood Volume Controller During Fluid Removal
US 8,556,846
Cited by 64 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Systems and Methods for Peritoneal Dialysis Having Point of Use Dialysis Fluid Preparation Including Mixing and Heating Therefore
US 10,828,412
Cited by 31 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2038.
Degassing Device and End-Cap Assembly for a Filter Including Such a Degassing Device
US 8,048,209
Cited by 43 later US patents, top 25% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 7 fees due Dec 6 to 30, 2026 · next Dec 6
- 4 fees due Jan 4 to 23, 2027 · next Jan 4
- 10 fees due Feb 1 to 28, 2027 · next Feb 1
- 6 fees due Mar 3 to 29, 2027 · next Mar 3
- 8 fees due Apr 8 to 29, 2027 · next Apr 8
- 5 fees due May 5 to 26, 2027 · next May 5
- 5 fees due Jun 3 to 29, 2027 · next Jun 3
- 5 fees due Jul 2 to 30, 2027 · next Jul 2
- 5 fees due Aug 6 to 25, 2027 · next Aug 6
- 9 fees due Sep 5 to 30, 2027 · next Sep 5
- 11 fees due Oct 2 to 23, 2027 · next Oct 2
- 3 fees due Nov 7 to 12, 2027 · next Nov 7
Recent changes
- Sep 24Assignment recorded on 1 record: Buck, Reinhold and 3 others to Gambro Lundia AB Recorded Sep 24, 2026, executed Jul 20, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76134, frame 92.
- 5 of the patents on this record were granted since Aug 20, 2026
- 3 terms have ended since Aug 20, 2026
What they patent
The 5 largest of its 313 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Degassing Device and End-Cap Assembly for a Filter Including Such a Degassing Device | 16 in force | to Jul 2033 |
| Extracorporeal Blood Treatment Flow Rate Adjustment | 4 in force | to Dec 2035 |
| Hemodialyzer for Blood Purification | 4 in force | to Apr 2035 |
| Membrane for Blood Purification | 4 in force | to Apr 2035 |
| Infusion Site for Improved Mixing of Fluids | 4 in force | to May 2029 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,914,049 | Hydraulic Connector and a Hydraulic Circuit Incorporating the Connector In force · High confidence | In force | High confidence | |
| US 7,935,258 | Process and an Apparatus for Filling And/Or Rinsing an Extracorporeal Blood Circuit In force · High confidence | In force | High confidence | |
| US 8,136,675 | Perm Selective Asymmetric Hollow Fibre Membrane for the Separation of Toxic Mediators from Blood In force · High confidence | In force | High confidence | |
| US 8,048,209 | Degassing Device and End-Cap Assembly for a Filter Including Such a Degassing Device In force · High confidence | In force | High confidence | |
| US 7,875,168 | Device for Calculating Blood Flow in an Extracorporeal Blood Circuit, and an Apparatus for Treatment of Blood Using the Device In force · High confidence | In force | High confidence | |
| US 9,364,604 | Extracorporeal Blood Treatment Machine In force · High confidence | In force | High confidence | |
| US 7,922,899 | Medical Apparatus and Method for Setting Up a Medical Apparatus In force · High confidence | In force | High confidence | |
| US 8,105,260 | Machine and Procedure for Extracorporeal Treatment of Blood In force · High confidence | In force | High confidence | |
| US 7,875,183 | Method of Removing Antibody Free Light Chains from Blood held by The Binding Site Group Limited and Gambro Lundia AB In force · High confidence | In force | High confidence | |
| US 9,050,421 | Follow-Up of the Vascular Access of a Dialyzed Patient In force · High confidence | In force | High confidence |
Also on record, not counted in the 415: 37 patents in force now held by others · 170 patents ended · 114 applications pending · 81 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.